AMARIN CORP PLCUK AMRN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1993-04-01
AMARIN CORP PLCUK statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 56.6% | 35.6% | 53.9% | 65.7% | 79.2% | 78.6% | 77.7% | 76.2% | 75.2% | 73.6% |
| Operating margin | -23.5% | -40.2% | -22.0% | -28.7% | 1.8% | -3.2% | -5.6% | -47.2% | -25.2% | -50.4% |
| Net margin | -18.2% | -35.9% | -19.3% | -28.7% | 1.3% | -2.9% | -5.3% | -50.8% | -37.5% | -66.4% |
| FCF margin | — | — | — | — | — | -3.6% | -2.8% | -41.3% | -18.1% | -55.2% |
| Return on assets | -5.8% | -12.0% | -7.1% | -11.9% | 0.7% | -1.9% | -2.6% | -30.2% | -42.0% | -51.7% |
| Return on equity | -8.4% | -16.9% | -10.7% | -17.8% | 1.2% | -2.9% | -3.7% | -76.4% | 104.2% | 953.3% |
| Debt / equity | — | — | — | — | — | — | 0.08× | 0.52× | -1.42× | -10.33× |
| Current ratio | 3.34 | 3.31 | 2.80 | 2.66 | 2.37 | 2.86 | 3.53 | 2.40 | 1.41 | 1.92 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.